Effects of prolonged tamoxifen treatment on receptor expression and apoptosis of ovarian cancer cells
| Autor: | Olaf Ortmann, Oliver Treeck, Felicitas Horn, Rong Zhou |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
medicine.medical_specialty
Receptor ErbB-2 Receptor expression Cell Estrogen receptor Apoptosis Cell Growth Processes Receptor tyrosine kinase Breast cancer Cell Line Tumor Internal medicine medicine Estrogen Receptor beta Humans skin and connective tissue diseases Ovarian Neoplasms biology business.industry Estrogen Receptor alpha Receptor Protein-Tyrosine Kinases Obstetrics and Gynecology medicine.disease ErbB Receptors Tamoxifen Endocrinology medicine.anatomical_structure Receptors Estrogen Oncology biology.protein Cancer research Female Poly(ADP-ribose) Polymerases business Ovarian cancer medicine.drug |
| Zdroj: | Gynecologic Oncology. 96:678-683 |
| ISSN: | 0090-8258 |
| DOI: | 10.1016/j.ygyno.2004.11.023 |
| Popis: | Objective Tamoxifen, which is widely used in the treatment of breast cancer, also has a beneficial effect on cisplatin-refractory ovarian cancer. In this study, we investigated the long-term effects of this drug on estrogen-receptor-positive ovarian cancer cells. Methods We performed an in vitro selection process by long-term treatment of BG-1 ovarian cancer cells with 4-hydroxy tamoxifen (4-OH TAM). Drug effects on cell growth were determined by measurement of relative cell numbers (MTS assay), the apoptotic effects of 4-OH TAM were determined by analysis of poly (ADP-ribose) polymerase (PARP) cleavage and by ELISA measurement of DNA–histone complexes in cytoplasm. Results Analysis of BG-1(LT) ovarian cancer cells isolated after 5 months of long-term treatment with 4-OH TAM revealed both a significantly reduced apoptotic and antiproliferative effect of this drug. Further experiments to examine expression changes of the receptor tyrosine kinases EGFR, HER2 and estrogen receptor α did not reveal any alterations in BG-1(LT) if compared to wild-type cells. In contrast, in this cell line, a significant alteration in the expression of estrogen receptor β was observed. Conclusion Our findings indicate that long-term treatment with 4-OH TAM is able to diminish both the antiproliferative and apoptotic action of this drug on BG-1 ovarian cancer cells. Our data suggest that the responsiveness of ovarian cancer cells to 4-OH TAM decreases after long-term treatment with this drug in vitro like previously observed after long-term treatment of breast cancer cells. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect